CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DAILY EQUITY REPORT

16TH february 2015

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN MARKET

INDIAN FACE

INDICES

CLOSE

PREVIOUS

SENSEX

29094.93

28805.10

NIFTY

8805.50

8711.55

for the fourth consecutive session after (SBI) managed to

ASIAN MARKET

stem rise in bad loans in its fiscal third quarter and reported

INDICES

CLOSE

PREVIOUS

NIKKEI

17,913.36

17,979.72

HANG SENG

24,682.54

24,422.15

KOSPI

1,957.50

1,941.63

30% increase in net profit for the December ended quarter.

Max India rose 3.22% after net profit spurted 346.8% to

Rs329.33 crore on 40.9% growth in total income to Rs416.44
crore in Q3 December 2014 over Q3 December 2013.

SECTORIAL INDICES
INDICES

CLOSE

CHANGE (%)

CNX 100

8,800.20

0.98

S&P CNX 500

7176.20

0.96

CNX MIDCAP

13,100.80

0.81

CNX 200

4,544.20

0.99

BANK NIFTY

19369.70

1.26

TOP GAINERS

CLOSE

CHANGE (%)

SBIN

307.70

8.23

M&M

1,191.05

4.99

LUPIN

1677.00

3.67

151.60

3.30

SpiceJet fell 2%, after the company reported a net loss of

Rs275.03 crore in Q3 December 2014, higher than net loss of
Rs172.80 crore in Q3 December 2013.

GLOBAL FACE

SCRIPT

JINDALSTEL

INDIAN EQUITY BENCHMARK continued their winning streak

Asian shares gained on news of a ceasefire accord in Ukraine,

while Sweden's surprise moves to cut its main rate into
negative territory and hopes of a resolution between debtstrapped Greece and its creditors burnished risk appetite.

European shares rose in early trading with robust growth

figures from Germany sending the country's blue-chip DAX

TOP LOSERS

index to a record high.

SCRIPT

CLOSE

CHANGE (%)

GAIL

405.45

-4.07

BHEL

259.40

-3.10

DLF

155.25

-2.20

ONGC

339.50

-2.01

US stock futures poised for a higher opening at the Wall Street

on Friday.

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

MARKET MOVERS UPSIDE

NIFTY SPOT

SCRIPT

CLOSE

TCS

2538.75

CHANGE
(%)
3.11

ITC

378.05

2.07

S3

S2

S1

0.92

8600

8693

8749

RELIANCE
COAL INDIA

917.50
377.85

2.47

TREND

STRATEGY

BULLISH

BUY ON DIPS
PIVOT POINTS
P
R1

8785

8841

SUPPORT
S1-8795
S2-8750

NIFTY

R2

R3

8878

8970

RESISTANCE
R1-8925
R2-8965

MARKET MOVERS DOWNSIDE

SCRIPT

CLOSE

ONGC

339.55

CHANGE
(%)
[1.99]

HDFC BNK

1065.80

[0.95]

INFOSYS

2296.10

[0.65]

TECHM

2886.55

[0.78]

FII & DII ACTIVITY

INSTITUTION

NET BUY
(CR.)

NET SELL
(CR)

FII

4589.36

4199.10

DII

2454.14

2358.32

BANK NIFTY FUTURE

TREND
BULLISH
PIVOT POINTS
S3

NSE TOTALS

18771

INDICES

ADVANCES

DECLINES

NIFTY

42

BANK NIFTY

STRATEGY
BUY ON DIPS

S2

S1

R1

19048

19208

19324

19485

BANK NIFTY

SUPPORT
S1-19150
S2-18995

R2

R3

19601

19878

RESISTANCE
R1-19580
R2-19750

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

r

MARKET TALKS

Positive for cash-strapped Suzlon (diversification, though thru

Lupin surges after RBI allows to raise

FII limit

personal capacity, by Sun Pharma promoters would be

sentimentally negative for Sun Pharma).

The Reserve Bank of India after market hours yesterday, February 12,
2015, announced hike in the ceiling on investment in shares of Lupin

by foreign institutional investors ( FIIs)/Registered Foreign Portfolios

Thomas Cook arm signs definitive

agreement to acquire Aramark

Investors ( RFPIs) under the portfolio investment scheme to 49% of

the company's equity capital with effect from February 12, 2015, from

Thomas Cook (India) announced that its subsidiary, Quess Group

earlier 33%.

has signed definitive agreement to acquire Aramark India from

Aramark, subject to regulatory approvals. Based out of Mumbai,

Aramark India is a facility management company offering niche

ICICI Pru Life looking at selling 5%

stake

offerings in hospitality and healthcare facility management. This

acquisition will strengthen Quess's position as a leading Pan
India.

ICICI Pru Life looking at selling 5% stake with company valuation of

US $6 billion (Rs37,000-37,500 crore) Positive for ICICI Bank
(sentimentally though upside to life insurance value does has less
than 5% impact on target price); more positive for Max India and Bajaj

Cipla to form a JV company in

Algeria

Finserv (life insurance forms over 60-85% of valuations).

Cipla (EU) will hold a 40% stake in the JV company while the
remainder will be held by a Biopharm-led Algerian consortium.

Promoters of Sun Pharma may buy

stake in Suzlon

The JV company is expected to make an investment of up to

USD 15 million in the construction of a manufacturing facility.
Cipla (EU)'s initial investment in cash in the JV company is

Suzlon Promoters of Sun Pharma could take stake in Suzlon

expected to be $ 6 million.

DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through
our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment
advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary
authority over your trading or investment accounts.
All rights reserved.